Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Omega 3 Fatty Acids Attenuated AKI to CKD Transition and Renal Fibrosis: Identification of Anti-Fibrotic Metabolites

Autor: Tokumaru, Kai, Watanabe, Hiroshi, Maruyama, Toru

Publikováno v: Journal of the American Society of Nephrology; November 2023, Vol. 34 Issue: 11, Number 11 Supplement 11 p698-698, 1p

Advanced Oxidation Protein Products Contribute to Renal Tubulopathy via Perturbation of Renal Fatty Acids.

Autor: Imafuku T; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.; Program for Leading Graduate Schools 'HIGO (Health Life Science: Interdisciplinary and Glocal Oriented) Program,' Kumamoto University, Kumamoto, Japan., Watanabe H; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Satoh T; Kumamoto Industrial Research Institute, Kumamoto, Japan., Matsuzaka T; Department of Internal Medicine (Endocrinology and Metabolism), Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.; Transborder Medical Research Center, University of Tsukuba, Ibaraki, Japan., Inazumi T; Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Kato H; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Tanaka S; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Nakamura Y; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Nakano T; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Tokumaru K; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Maeda H; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Mukunoki A; Division of Reproductive Engineering, Center for Animal Resources and Development, Kumamoto University, Kumamoto, Japan., Takeo T; Division of Reproductive Engineering, Center for Animal Resources and Development, Kumamoto University, Kumamoto, Japan., Nakagata N; Division of Reproductive Engineering, Center for Animal Resources and Development, Kumamoto University, Kumamoto, Japan., Tanaka M; Department of Nephrology, Akebono Clinic, Kumamoto, Japan., Matsushita K; Department of Nephrology, Akebono Clinic, Kumamoto, Japan., Tsuchiya S; Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Sugimoto Y; Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan., Shimano H; Department of Internal Medicine (Endocrinology and Metabolism), Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.; Japan Agency for Medical Research and Development-Core Research for Evolutional Science and Technology, Tokyo, Japan., Fukagawa M; Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Kanagawa, Japan., Maruyama T; Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.

Publikováno v: Kidney360 [Kidney360] 2020 Jun 03; Vol. 1 (8), pp. 781-796. Date of Electronic Publication: 2020 Jun 03 (Print Publication: 2020).